Phenomix Sciences
Healthcare Software · Minnesota, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
18202 Minnetonka Blvd, Wayzata, Minnesot...Website
www.phenomixsciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Phenomix Sciences
Phenomix Sciences specializes in AI-driven precision obesity medicine, integrating genetic, clinical, and biomarker data to optimize treatment outcomes. Their MyPhenome Test is designed to identify the root causes of obesity and recommend the most effective therapeutic pathways. The company aims to support clinicians in delivering timely and appropriate interventions, thereby reducing costs and improving patient compliance. Targeting healthcare providers and patients, Phenomix is at the forefront of transforming obesity care through innovative data analytics and personalized medicine.Explore more
Phenomix Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phenomix Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Phenomix Sciences had a recent Job posting/layoffs
Check out if Phenomix Sciences is spiking on competitors!
Product Launch: Get notified when Phenomix Sciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Phenomix Sciences
Earning: See what the market has to say on Phenomix Sciences recently announced quarterly report
Phenomix Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Phenomix Sciences has new funding data
Check if Phenomix Sciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Phenomix Sciences
Compare insights from companies similar to Phenomix Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phenomix Sciences is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Phenomix Sciences is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Phenomix Sciences.
Phenomix Sciences financials insights
Gather financial insights about Phenomix Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Grant
$2.3M
Series A
$5.5M
Phenomix Sciences Tech Stack
A closer look at the technologies used by Phenomix Sciences
See more technologies
Phenomix Sciences News & Media
Phenomix Sciences Report Finds Patients See GLP-1s as Progress, Not a Cure; Want More Guidance on Long-Term Care
National survey shows patient expectations and perceptions of GLP-1s are evolving, and clearer education is shaping obesity treatment decisions. GLP-1s are viewed as progress, not a cure: Most patients (54%) see GLP-1s as a meaningful step forward while recognizing obesity as a long-term...More Than Half of GLP-1 Users Reported Seeking Follow-Up Care for Side Effects, Phenomix Sciences Report Finds
In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care. Real-world response varies: Many...Phenomix Sciences Expands Evidence for MyPhenome™ Test Predicting GLP-1 Response and Obesity Risk in Large, Diverse Populations
Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in diverse patient populations and post-bariatric surgery patients. Phenomix's MyPhenome test continues to demonstrate predictive accuracy in...Phenomix and Mayo Clinic Publish Research Demonstrating Utility of MyPhenome Test for Personalized GLP-1 and Phen-Top Treatment
Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenome™ test can help providers guide obesity treatment by matching patients to GLP-1s or phentermine/topiramate based on their unique biology. MENLO PARK, Calif., June 10, 2025 /PRNewswire/ -- Phenomix...
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phenomix Sciences
Sign Up For FreeTo access detailed company insights
Phenomix Sciences specializes in AI-driven precision obesity medicine, integrating genetic, clinical, and biomarker data to optimize treatment outcomes. Their MyPhenome Test is designed to identify the root causes of obesity and recommend the most effective therapeutic pathways. The company aims to support clinicians in delivering timely and approp... Read More
